Annual General Meeting in SCN Elects Anders Uddén New Member of the Board

At the Annual General Meeting in Scandinavian Clinical Nutrition i Sverige AB (publ) today, May 22, 2008, Anders Uddén and Thomas Christensen were elected new Members of the Board.

“I am very glad that Anders Uddén has been elected new Member of the Board of SCN. His extensive experience from company building and international sales expansion from the Swedish company Permobil will be a great asset for SCN when we are building our own presence on the international market”, says Carsten Waern, Chairman of the Board.

“In my opinion, SCN has a promising business case in making natural products with scientific documentation. The product portfolio is interesting, and with the impressive R&D and distribution network that the company has in place – even on the US market – I see great potential for future growth. I also have strong faith in the people involved in the company, and look forward to contributing to their competence with my experiences”, says Anders Uddén.

The other newly elected Board Member, Thomas Christensen, has been the company’s CFO since January 1, 2008. Like Anders Uddén he has extensive international experience, predominantly from USA, from both executive positions and Board assignments. In addition to Anders Uddén and Thomas Christensen, the SCN Board of Directors consists of Jörn Erik Aas, Carsten Waern and Ulf Söderberg, all of which were re-elected by the Annual General Meeting.

The following decisions were also made at the Annual General Meeting (AGM):

Proposed Appropriation of Retained Earnings
The AGM decided that the net loss for the year is deducted from share premium reserve and that profit from last year is carried forward. The company does not propose any dividends to be paid.

Director’s Fees
The AGM decided that the Chairman of the Board is to receive SEK 200,000 in remuneration, and the other Directors not employed by the company are to receive SEK 100,000. The auditor’s fee is to continue to be paid against an approved invoice.

Authorizations
The AGM decided to authorize the Board to issue up to 6,000,000 new shares, convertible debentures or warrants until the next AGM, on one or more occasions, with or without right of priority for the current shareholders. Issuances shall be done on market terms, with reservation for market rated issue discounts when applicable, and with or without provision of contribution or set-off. The AGM also decided to authorize the Board to purchase the Company's own shares on one or more occasions until the next AGM, not exceeding 10 percent of the total number of shares in the company, and at a price formed during public trading.


For more information, please contact:
Ulf Söderberg, CEO, us@scnutrition.com, +46 708 13 22 81
Thomas Christensen, CFO, tc@scnutrition.com, +47 922 55 444